Bioventus Inc. (BVS)
SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 27, 2026 · updated Oct 6, 2026
as filed in 10-Q FY2026, period ended Jun 27, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Jun 27, 2026, Bioventus Inc. reported revenue of $153.2M, net income of $33.4M, and total assets of $673.3M. Every figure below is taken directly from Bioventus Inc.'s SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2019–FY2025 · as reported
- FY2019 revenue
- $340.1M
- FY2025 revenue
- $568.1M
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2025 | $568.1M | $22.7M |
| FY2024 | $573.3M | -$36.1M |
| FY2023 | $512.3M | -$156.2M |
| FY2022 | $512.1M | -$158.7M |
| FY2021 | $430.9M | $19.4M |
| FY2020 | $321.2M | $16.4M |
| FY2019 | $340.1M | $6.9M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Aug 5, 2026 | on EDGAR ↗ |
| 10-Q | Aug 5, 2026 | on EDGAR ↗ |
| 8-K | Jun 4, 2026 | on EDGAR ↗ |
| 8-K | May 21, 2026 | on EDGAR ↗ |
| 8-K | May 6, 2026 | on EDGAR ↗ |
| 10-Q | May 6, 2026 | on EDGAR ↗ |
| DEF 14A | Apr 22, 2026 | on EDGAR ↗ |
| 10-K | Mar 5, 2026 | on EDGAR ↗ |
| 8-K | Mar 5, 2026 | on EDGAR ↗ |
| 8-K | Nov 17, 2025 | on EDGAR ↗ |
Balance Sheet
as of Jun 27, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Jun 27, 2026
| Revenue | $153.2M | Revenue | source ↗ |
| Net Income | $33.4M | Net | source ↗ |
| Operating Income | $19.1M | Operating | source ↗ |
| Gross Profit | $105.7M | Gross | source ↗ |
| Cost of Revenue | $47.5M | Cost | source ↗ |
| R&D Expense | $3.2M | Research | source ↗ |
Per Share & Cash Flow
10-Q (quarterly) · period ended Jun 27, 2026
| EPS (diluted) | $0.47 | Earnings | source ↗ |
| EPS (basic) | $0.49 | Earnings | source ↗ |
| Shares Outstanding | 70.4M | Weighted | source ↗ |
| Cash from Operations | $19.9M | Net | source ↗ |
| Cash from Financing | -$23.4M | Net | source ↗ |
| Cash from Investing | -$2.5M | Net | source ↗ |
Insider activity
Form 4 open-market activity, last 180 days
No open-market Form 4 transactions filed in the last 180 days.
Restatement history
Point-in-time16 of 193 annual fact-keys were materially restated between filings: what Bioventus Inc. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.
See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.
Deeper fundamentals
A free API key reaches BVS’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/BVS
MCP tool:
get_sec_fundamentals ticker=BVS - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/BVS/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=BVS as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/BVS/history
MCP tool:
get_fundamentals_history ticker=BVS - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/BVS
MCP tool:
get_financial_health ticker=BVS
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.